Trials / Recruiting
RecruitingNCT06396871
Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (estimated)
- Sponsor
- Technische Universität Dresden · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The goal of this cross-sectional observational study is to to perform a thorough characterization of the quantitative and qualitative differences in peripheral blood cells, and circulating factors (proteins, metabolites, lipids, extracellular vesicles) in different stages of several metabolic diseases (diabetes, obesity, non-alcoholic fatty liver disease) that share common pathophysiological mechanisms and in comparison with adult healthy controls. The main question\[s\] it aims to answer are: * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in platelets in patients with metabolic diseases vs subjects without metabolic diseases * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in leucocytes or circulating molecules in patients with metabolic diseases vs subjects without metabolic diseases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Oral glucose tolerance test | 75g of a standardized glucose solution followed by blood draw at 0, 30, 60, 90, 120 min |
| DIAGNOSTIC_TEST | Liver Ultrasound | A crude assessment of liver status in order to identify the presence of steatosis or not will take place with ultrasound. |
| DIAGNOSTIC_TEST | Fibroscan of the Liver | FibroScan non-invasively measures the stiffness of the liver by capturing and calculating the speed of a shear wave as it travels through the liver (vibration controlled transient elastography). |
| DIAGNOSTIC_TEST | Magentic Resonance Imaging (MRI) of the liver | The exact calculation of liver fat with proton density fat fraction will take place with MRI. |
Timeline
- Start date
- 2023-10-16
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2024-05-02
- Last updated
- 2024-05-02
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06396871. Inclusion in this directory is not an endorsement.